A retrospective study assessing effectiveness of lenvatinib monotherapy among previously treated unresectable hepatocellular carcinoma patients in United States clinical practices
Latest Information Update: 19 Jul 2021
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology